Next Big Thing in Biotech: Cancer Drug Stocks
Senior columnist Adam Feuerstein explains why cancer drug stocks are the next big thing in biotech.
Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.
